EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Augmented type 2 inflammatory response in allergic rhinitis patients experiencing systemic reactions to house dust mite subcutaneous immunotherapy

Ping Ji, Lin Yang, Li Zhu, Lintao Hu, Yin Wang, Cancan Shi, Qing Jiang, Nan Huang, Yaqi Yang iD, Hao Chen iD, Rongfei Zhu iD

Pediatric Allergy and Immunology · 2024

DOI: 10.1111/pai.14207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, 2024. Verfasst von Ping Ji und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Rhinitis, Allergic, Pyroglyphidae. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Subcutaneous immunotherapy (SCIT) can induce systemic reactions (SRs) in certain patients, but the underlying mechanisms remain to be fully elucidated.

Methods

AR patients who were undergoing standardized HDM SCIT (Alutard, ALK) between 2018 and 2022 were screened. Those who experienced two consecutive SRs were included in the study group. A control group was established, matched 1:1 by gender, age, and disease duration with the study group, who did not experience SRs during SCIT. Clinical and immunological parameters were recorded and analyzed both before SCIT and after 1 year of treatment.

Results

A total of 161 patients were included, with 79 (49.07%) in the study group. The study group had a higher proportion of AR combined asthma (26.8% vs. 51.8%, p < 0.001) and higher levels of sIgE to HDM and HDM components (all p < .001). Serum IL‐4 and IL‐13 levels in the study group were higher than those in the control group ( p < .05). The study group received a lower maintenance dosage of HDM extracts injections than control group due to SRs (50000SQ vs. 100000SQ, p < .05). After 1 year of SCIT, the VAS score, the lung function parameters of asthmatic patients over 14 years old significantly improved in both groups (all p < .05). After a 7‐day exposure to 20 μg/mL HDM extracts, the percentages of Th1, Th17, Tfh10, and Th17.1 in PBMCs decreased, while the Tfh13 cells significantly increased in the study group ( p < .05).

Conclusion

The type 2 inflammatory response is augmented in HDM‐induced AR patients who experienced SRs during SCIT. Despite this, SCIT remains effective in these patients when administered with low‐dosage allergen extracts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Desensitization, ImmunologicRhinitis, AllergicPyroglyphidaeHumansMaleFemaleChildInjections, SubcutaneousAnimalsAdolescentAntigens, DermatophagoidesAsthmaImmunoglobulin EAllergensTh2 Cells

Stichwörter der Autor:innen

CD4+T cellallergic rhinitiscytokineshouse dust mitesubcutaneous immunotherapysystemic reactions

Substanzen

Antigens, DermatophagoidesImmunoglobulin EAllergens

Autor:innen und Institutionen

  • Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Institute of Allergy and Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

ORCID-Profile: Yaqi Yang, Hao Chen, Rongfei Zhu

Zitieren

APA

Ji, P., Yang, L., Zhu, L., Hu, L., Wang, Y., Shi, C., Jiang, Q., Huang, N., Yang, Y., Chen, H., & Zhu, R. (2024). Augmented type 2 inflammatory response in allergic rhinitis patients experiencing systemic reactions to house dust mite subcutaneous immunotherapy. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.14207

Vancouver

Ji P, Yang L, Zhu L, Hu L, Wang Y, Shi C, et al. Augmented type 2 inflammatory response in allergic rhinitis patients experiencing systemic reactions to house dust mite subcutaneous immunotherapy. Pediatric Allergy and Immunology. 2024. doi:10.1111/pai.14207

BibTeX
@article{Ji2024,
  author = {Ji, Ping and Yang, Lin and Zhu, Li and Hu, Lintao and Wang, Yin and Shi, Cancan and Jiang, Qing and Huang, Nan and Yang, Yaqi and Chen, Hao and Zhu, Rongfei},
  title = {Augmented type 2 inflammatory response in allergic rhinitis patients experiencing systemic reactions to house dust mite subcutaneous immunotherapy},
  journal = {Pediatric Allergy and Immunology},
  year = {2024},
  doi = {10.1111/pai.14207}
}
Kostenlos starten →